loadpatents
name:-0.024805068969727
name:-0.013739824295044
name:-0.0036299228668213
Mihalic; Jeffrey Thomas Patent Filings

Mihalic; Jeffrey Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mihalic; Jeffrey Thomas.The latest application filed is for "piperidinone derivatives as mdm2 inhibitors for the treatment of cancer".

Company Profile
2.10.18
  • Mihalic; Jeffrey Thomas - San Francisco CA
  • Mihalic; Jeffrey Thomas - San Carlos CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20220169611 - Bartberger; Michael D. ;   et al.
2022-06-02
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20210179560 - Bartberger; Michael D. ;   et al.
2021-06-17
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20190062276 - Bartberger; Michael D. ;   et al.
2019-02-28
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20170144971 - BARTBERGER; Michael D. ;   et al.
2017-05-25
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,593,129 - Bartberger , et al. March 14, 2
2017-03-14
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
Grant 9,376,425 - Bartberger , et al. June 28, 2
2016-06-28
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20160137667 - BARTBERGER; Michael D. ;   et al.
2016-05-19
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,296,736 - Bartberger , et al. March 29, 2
2016-03-29
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140315895 - Bartberger; Michael D. ;   et al.
2014-10-23
Heterocyclic Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140235629 - Bartberger; Michael D. ;   et al.
2014-08-21
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140011796 - BARTBERGER; Michael David ;   et al.
2014-01-09
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20110319378 - BARTBERGER; Michael David ;   et al.
2011-12-29
Fused heterocyclic compounds
App 20080058365 - Chen; Xi ;   et al.
2008-03-06
Fused heterocyclic compounds
Grant 7,253,179 - Chen , et al. August 7, 2
2007-08-07
Fused heterocyclic compounds
App 20070135425 - Chen; Xiaoqi ;   et al.
2007-06-14
Antibacterial agents
Grant 7,148,259 - Li , et al. December 12, 2
2006-12-12
Antibacterial Agents
App 20060270651 - Li; Leping ;   et al.
2006-11-30
Fused heterocyclic compounds
Grant 7,125,885 - Chen , et al. October 24, 2
2006-10-24
Antibacterial agents
Grant 7,053,234 - Li , et al. May 30, 2
2006-05-30
Fused heterocyclic compounds
App 20050148617 - Chen, Xiaoqi ;   et al.
2005-07-07
Fused heterocyclic compounds
Grant 6,858,619 - Chen , et al. February 22, 2
2005-02-22
Antibacterial agents
App 20040235911 - Li, Leping ;   et al.
2004-11-25
Fused heterocyclic compounds
Grant 6,809,104 - Chen , et al. October 26, 2
2004-10-26
Antibacterial agents
Grant 6,780,858 - Li , et al. August 24, 2
2004-08-24
Fused heterocyclic compounds
App 20040147538 - Chen, Xi ;   et al.
2004-07-29
Fused heterocyclic compounds
App 20030176694 - Chen, Xiaoqi ;   et al.
2003-09-18
Fused heterocyclic compounds
App 20030023085 - Chen, Xiaoqi ;   et al.
2003-01-30
Antibacterial agents
App 20020045749 - Li, Leping ;   et al.
2002-04-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed